Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Mexico Clear all

257 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20034
200412
20056
200617
20078
200830
200920
201022
201114
201218
201310
201411
20158
20169
201711
20185
201910
20204
20214
20226
20237
20246
20253
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed218
Terminated15
Recruiting9
Active, not recruiting5
Withdrawn3
Not yet recruiting3
Unknown status3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca48
Eli Lilly and Company44
Novo Nordisk A/S38
Sanofi20
Takeda17
Boehringer Ingelheim16
Hoffmann-La Roche13
Janssen Research & Development, LLC10
GlaxoSmithKline9
Daiichi Sankyo6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2257
Diabetes Mellitus77
Glucose Metabolism Disorders21
Metabolic Diseases14
Endocrine System Diseases12
Renal Insufficiency, Chronic10
Dyslipidemias9
Hyperglycemia8
Cardiovascular Diseases7
Obesity7

Trials

Showing 1 to 25 of 257. Each trial links to its page on Pharma Observatory.

157 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.